BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:CFT8919 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of CFT8919\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06641609-2436@assetmemo.bio
DTSTAMP:20261121T005352Z
DTSTART;VALUE=DATE:20270630
DTEND;VALUE=DATE:20270701
SUMMARY:CFT8919: Phase 1 readout est. (NCT06641609)
DESCRIPTION:CFT8919\, phase 1\, Non-Small Cell Lung Cancer.\nStudy: A Phase
  I Study of CFT8919 in Patients With Advanced NSCLC\nEstimated primary com
 pletion: June 2027. This is a ClinicalTrials.gov estimate\, not a confirme
 d readout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/c
 ft8919#upcoming-events\nRegistry record: https://clinicaltrials.gov/study/
 NCT06641609
URL:https://assetmemo.bio/drug/cft8919#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
